Researchers have developed a vaccine that is effective, in mice, against hypervirulent strains of Klebsiella that can cause life-threatening infections in healthy adults. Scientists have produced ...

Researchers have discovered that plant-derived phytochemicals and their gut microbiome metabolites control the effectiveness ...

A mouse study at Washington University School of Medicine in St. Louis points to data that could be key to developing an effective vaccine for the bacterium Klebsiella pneumoniae. The bug is often ...

Fig b (infection by a lower bacterial dose) shows that the mice infected with 14WZ-24-TC1, i.e., classic ST11 carbapenem-resistant Klebsiella pneumoniae strain carrying plasmid, all died after 120 ...

Scientists are working on vaccines for Klebsiella, but the optimal vaccine design is still unknown. However, a new study in mice by scientists at Washington University School of Medicine in St ...

KPC Development has broken ground on a $300 million hotel in Inglewood, the only lodge inside Stan Kroenke’s Hollywood Park and SoFi Stadium development. The unit of Corona-based KPC Group led ...

Thankfully a new vaccine has shown promise against the bug in tests on mice. “For a long time, Klebsiella was primarily an issue in the hospital setting, so even though drug resistance was a ...

Scientists at the National Institutes of Health have used two different bacteriophage viruses individually and then together to successfully treat research mice infected with multidrug-resistant ...

Scientists have produced and tested, in mice, a vaccine that protects against a worrisome superbug: a hypervirulent form of the bacteria Klebsiella pneumoniae. And they’ve done so by genetically ...